-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Guide
Medical pulse through the collation from: medical pulse tong.
In 2019, Xiaobian launched the "Knowledge Card" column, which organizes some clinical disease-related knowledge points in the form of simple and easy-to-save tables, so that clinicians can use fragmented time to learn from the past, which is quite popular with doctor readers! Xiaobian will continue to sort out clinical knowledge points in the form of tables in order to help
clinicians.
Compiled and sorted out, please do not reprint
without authorization.
Drug overuse headache (MOH) is a chronic secondary headache caused by frequent or regular use of analgesics or acute antimigraine drugs for
primary headaches.
According to the classification of the International Headache Society (ICHD-3), MOH is defined as taking headache medications regularly for 10 or 15 days per month on the basis of primary headache≥s (analgesic drugs alone, taking ≥ 15 days / month; For triptan, ergotamine, opioids, and combination analgesics, take ≥10 days/month) for more than 3 months, and headaches
occur for 15 days or more per month.
Prophylactic treatment without discontinuation can reduce the frequency of headaches or migraines and the use of acute medications in the case of unintentional withdrawal (discontinuation) and is a reasonable approach
for patients with excessive use of analgesics or triptans.
Prophylactic treatment without discontinuation may be the treatment option
for patients with difficulty stopping the drug.
In patients who overuse opioids or analgesics containing barbiturates, and in patients with severe comorbidities (such as psychiatric disorders and epilepsy), the main treatment option is discontinuation (Figure 1
).
Figure 1 Recommended course of treatment for drug overuse headaches
Note: NSAID = NSAIDs; CGRP = calcitonin gene-related peptide
.
Medical pulse through the collation from: medical pulse tong.